Download PDF
Planta Med 1992; 58(5): 394-397
DOI: 10.1055/s-2006-961499
Paper

© Georg Thieme Verlag Stuttgart · New York

Choleretic Effects of α-Iridodiol on Experimentally Induced Intrahepatic Cholestasis

Yasuhiro Mizoguchi, Chihiro Sakagami, Yuzo Ichikawa, Kenzo Kobayashi
  • The Third Department of Internal Medicine. Osaka City University Medical School, 1-5-7 Asahi-machi, Abeno-ku, Osaka 545, Japan
Further Information

Publication History

1991

Publication Date:
05 January 2007 (online)

Also available at
  PDF Download Buy Article Permissions and Reprints
Zoom Image

Abstract

When a lymphokine, the cholestatic factor, was intravenously injected into rats through a mesenteric vein, a remarkable reduction in bile flow was observed. Using this experimentally induced intra-hepatic cholestasis model, we studied the choleretic effects of α-iridodiol, an iridoid compound. When α-iridodiol was administered 30 min before, at the same time, or 30 min after injection of the cholestatic factor, the reductions in bile flow and bile acid excretion were significantly inhibited. Remarkable choleretic effects were also noted when it was administered to normal rats. These results suggested that α-iridodiol may be effective in the treatment of intrahepatic cholestasis.

Key words

α-Iridodiol - cholestatic factor - intrahepatic cholestasis